Rhythm Pharmaceuticals, Inc. (RYTM)
85.69
-2.17
(-2.47%)
USD |
NASDAQ |
Jun 10, 16:00
85.70
+0.01
(+0.01%)
After-Hours: 20:00
Rhythm Pharmaceuticals Debt to Equity Ratio : 1.847 for March 31, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| March 31, 2026 | 1.847 |
| December 31, 2025 | 1.748 |
| September 30, 2025 | 1.747 |
| June 30, 2025 | -21.79 |
| March 31, 2025 | 13.60 |
| December 31, 2024 | 11.81 |
| September 30, 2024 | 22.72 |
| June 30, 2024 | 6.422 |
| March 31, 2024 | 1.761 |
| December 31, 2023 | 0.6327 |
| September 30, 2023 | 0.5375 |
| June 30, 2023 | 0.4441 |
| March 31, 2023 | 0.3608 |
| December 31, 2022 | 0.2942 |
| September 30, 2022 | 0.0075 |
| June 30, 2022 | 0.0115 |
| March 31, 2022 | 0.0102 |
| December 31, 2021 | 0.009 |
| September 30, 2021 | 0.0084 |
| June 30, 2021 | 0.008 |
| March 31, 2021 | 0.0078 |
| December 31, 2020 | 0.0185 |
| Date | Value |
|---|---|
| September 30, 2020 | 0.0163 |
| June 30, 2020 | 0.0148 |
| March 31, 2020 | 0.0136 |
| December 31, 2019 | 0.0127 |
| September 30, 2019 | 0.0246 |
| June 30, 2019 | 0.0204 |
| March 31, 2019 | 0.0165 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | 0.00 |
| September 30, 2015 | |
| December 31, 2014 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.0407 |
| Biogen, Inc. | 0.3518 |
| Regeneron Pharmaceuticals, Inc. | 0.0861 |
| Vertex Pharmaceuticals, Inc. | 0.1026 |
| AbbVie, Inc. | -10.95 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 442.32M |
| Total Liabilities (Quarterly) | 319.41M |
| Shareholders Equity (Quarterly) | 122.91M |
| Current Ratio | 4.168 |
| Net Debt Paydown Yield | 0.10% |